Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer’s disease with hydromethylthionine mesylate using external control data
- Digital Object Identifier
- https://doi.org/10.1016/j.tjpad.2026.100560
- Open Access
- http://aura.abdn.ac.uk/bitstreams/d20e53ba-6471-4ae9-bf44-59d0e2633939/download